Analyst consensus rating
Assembly Biosciences Analyst Rating: Strong Buy
ASMB is rated Strong Buy by 4 analysts with a $50.00 target. As of 2026-08-29.
Direct answer
Assembly Biosciences's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $50.00.
Forecast evidence checked August 29, 2026.
Get free Assembly Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $34.07
- Average price target
- $50.00
- High price target
- $62.00
- Low price target
- $43.00
- Low target gap
- +26.2%
- Target upside
- +46.8%
- High target gap
- +82%
- Target range width
- 55.8%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Assembly Biosciences?
Assembly Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $50.00.
How far are Assembly Biosciences's low and high targets from the recorded price?
The low target implies +26.2%, while the high target implies +82%.
How many analysts are included in Assembly Biosciences's consensus?
The verified consensus includes 4 analysts.
How is Assembly Biosciences's target upside or downside calculated?
The average target of $50.00 is divided by the recorded price of $34.07, then one is subtracted to produce +46.8%. This does not guarantee a future return.
When was Assembly Biosciences's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.